Sep 17, 2024
BIOASIS TECHNOLOGIES INC. (TSXV:BTI.H) (the "Company" or "Bioasis") a biopharmaceutical company with a differentiated, proprietary platform (designated "xB3 ™") for delivering therapeutics across the blood-brain barrier ("BBB") and the treatment of...